Webinar Recap: Kappa and Lambda Free Light Chains in Plasma Cell Disorders
22nd Apr 2026
Abbott recently hosted a webinar exploring the clinical role of kappa and lambda free light chain testing in the diagnosis and monitoring of plasma cell disorders such as multiple myeloma.
Key points include the use of the kappa/lambda ratio to identify abnormal monoclonal protein production and how free light chain assays complement serum protein electrophoresis and immunofixation to support more accurate diagnosis. The webinar also covers re-baselining in patient monitoring, particularly during treatment, where changes in results must be interpreted in clinical context over time.
Watch the full webinar here: https://app.webinar.net/NGbzB1VygYm/on-demand?token=NjEzOTQ4MTAtYzEyNy00ODA0LThmMWQtM2EyYzU2ZTc5YzM1O2N5dWFuQGRpYXp5bWUuY29tOzY5YzAxMTYxZDIyZDYwYTU3OWRmZjdiZg%3D%3D
Credit to Abbott as the sponsor and host of the webinar.